GENVIP – Publications

Publications

Since 2007 GENVIP has published more than 430 publications

SAFETY AND IMMUNOGENICITY OF PNEUMOCOCCAL CONJUGATE VACCINES IN PRETERM INFANTS

Carolina López-Sanguos, Irene Rivero Calle, Carmen Rodriguez Tenreiro, Peter Francis Raguindin and Federico Martinón-Torres

Pubmed Full article

Doi:

Expert Opin Drug Saf

Factor de impacto:

Q2

Doi:

¿QUÉ HEMOS APRENDIDO SOBRE ROTAVIRUS EN ESPAÑA EN LOS ÚLTIMOS 10 AÑOS?

Javier Díez-Domingo, María Garcés-Sánchez, Francisco Giménez-Sánchez, Javier Colomina-Rodríguez, Federico Martinón-Torres

Pubmed Full article

Doi:

An Pediatr (Barc)

Factor de impacto:

Q3

Doi:

LIFESTYLE AND COMORBID CONDITIONS AS RISK FACTORS FOR COMMUNITY-ACQUIRED PNEUMONIA IN OUTPATIENT ADULTS (NEUMO-ES-RISK project)

Irene Rivero-Calle, Miriam Cebey-López, Jacobo Pardo-Seco, José Yuste, Esther Redondo, Diego A Vargas, Enrique Mascarós,Jose Luis Díaz-Maroto, Manuel Linares-Rufo, Isabel Jimeno, Angel Gil, Jesus Molina, Daniel Ocaña,Federico Martinón-Torres, on behalf of NEUMOEXPERTOS group

Pubmed Full article

Doi:

BMJ Open Respir Res

Factor de impacto:

Doi:

EFFICACY, IMMUNOGENICITY, AND SAFETY OF A QUADRIVALENT INACTIVATED INFLUENZA VACCINE IN CHILDREN AGED 6–35 MONTHS: A MULTI-SEASON RANDOMISED PLACEBO-CONTROLLED TRIAL IN THE NORTHERN AND SOUTHERN HEMISPHERES

Stephanie Pepin, Martin Dupuy, Charissa Fay Corazon Borja-Tabora, May Montellanoc, Lulu Bravo, Jaime Santos, Jo-Anne de Castro, Doris Maribel Rivera-Medina, Clare Cutland, Miguel Ariza, Javier Diez-Domingo, Celia Diaz Gonzalez, Federico Martinón-Torres, Efimia Papadopoulou-Alataki, Maria Theodoriadou, Marie Pierre Kazek-Duret, Sanjay Gurunathan, Iris De Bruijn, for the GQM05 Study Group

Pubmed Full article

Doi:

Vaccine

Factor de impacto:

Q2

Doi:

ROTAVIRUS INFECTION BEYOND THE GUT

José Gómez-Rial, Sonia Sánchez-Batán, Irene Rivero-Calle, Jacobo Pardo-Seco, José María Martinón-Martínez, Antonio Salas, Federico Martinón-Torres

Pubmed Full article

Doi:

Infection and Drug Resistance

Factor de impacto:

Q2

Doi:

IMPLEMENTING UNIVERSAL VARICELLA VACCINATION IN EUROPE: THE PATH FORWARD

Vana Spoulou, Sophie Alain, Giovanni Gabutti, Carlo Giaquinto, Johannes Liese, Federico Martinon-Torres and Timo Vesikari

Pubmed Full article

Doi:

Pediatric Infect Dis J

Factor de impacto:

Q2

Doi:

Descripción de la gripe B en las epidemias estacionales de España

Raúl Ortiz de Lejarazu, Javier Diez Domingo, Ángel Gil de Miguel, Federico Martinón-Torres, Carlos Guzmán Quilo, José María Guillén, Blanca Piedrafita, Esther Redondo Marguello

Pubmed Full article

Doi:

Rev, Esp. Quimioterapia

Factor de impacto:

Q4

Doi:

EVALUATION OF A HEXAVALENT-PENTAVALENT-HEXAVALENT INFANT PRIMARY VACCINATION SERIESFOLLOWED BY A PENTAVALENT BOOSTER VACCINE IN HEALTHY INFANTS AND TODDLERS

Federico Martinόn-Torres, Javier Diez-Domingo, Emmanuel Feroldi, Emilia Jordanov, Siham B’Chir, and Xavier Da Costa, Hospital Clinico Universitario de Santiago de Compostela, Spain;FISABIO-Public Health,Valencia, Spain; Sanofi Pasteur, France; Sanofi Pasteur, USA

Pubmed Full article

Doi:

Pediatric Infect Dis J

Factor de impacto:

Q2

Doi:

ANAMNESTIC IMMUNE RESPONSE AND SAFETY OF AN INACTIVATED QUADRIVALENT INFLUENZA VACCINE IN PRIMED VERSUS VACCINE-NAÏVE CHILDREN

Claeys C, Chandrasekaran V, García-Sicilia J, Prymula R, Díez-Domingo J, Brzostek J, Marès-Bermúdez J, Martinón-Torres, Pollard AJ, Růžková R, Martinez AC, Ulied A, Valdivieso MM, Faust SN, Snape MD, Friel D, Ollinger T, Soni J, Schuind A, Li P, Innis BL, Jain VK.

Pubmed Full article

Doi:

Pediatric Infect Dis J

Factor de impacto:

Q2

Doi:

ADULT COMMUNITY ACQUIRED PNEUMONIA VACCINATION: 2018 UPDATE OF THE POSITIONING OF THE PNEUMONIA PREVENTION EXPERT GROUP

Redondo E, Rivero-Calle I, Vargas DA, Mascarós E, Díaz-Maroto JL, Linares M, Gil A, Molina J, Jimeno I, Ocaña D, Yuste JE, Martinón-Torres F, en nombre de Neumoexpertos en Prevención

Pubmed Full article

Doi:

Semergen

Factor de impacto:

Doi:

A STRATEGY TARGETING MONOCYTE-MACROPHAGE DIFFERENTIATION TO AVOID PULMONARY COMPLICATIONS IN SARS-COV2 INFECTION

J.Gómez-Rial, F.Martinón-Torres

Clin Immunol

Factor de impacto:

Q2

Doi:

Pubmed Full article

MAPPING GENOME VARIATION OF SARS-COV-2 WORLDWIDE HIGHLIGHTS THE IMPACT OF COVID-19 SUPER-SPREADERS

Alberto Gómez-Carballa, Xabier Bello, Jacobo Pardo-Seco, Federico Martinón-Torres, Antonio Salas

bioRxiv

Factor de impacto:

Q1

Doi:

Pubmed Full article

CLINICAL CHARACTERISTICS OF 58 CHILDREN WITH A PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME TEMPORALLY ASSOCIATED WITH SARS-COV-2

Elizabeth Whittaker; Alasdair Bamford; Julia Kenny; Myrsini Kaforou; Christine E. Jones; Priyen Shah; Padmanabhan Ramnarayan; Alain Fraisse; Owen Miller; Patrick Davies; Filip Kucera; Joe Brierley; Marilyn McDougall; Michael Carter; Adriana Tremoulet; Chisato Shimizu Jethro Herberg; Jane C. Burns; Hermione Lyall; Michael Levin; for the PIMS-TS Study Group and EUCLIDS and PERFORM Consortia (Federico Martinón-Torres)

JAMA

Factor de impacto:

Q1

Doi:

Pubmed Full article

RNA-SEQ DATA-MINING ALLOWS THE DISCOVERY OF TWO LONG NON-CODING RNA BIOMARKERS OF VIRAL INFECTION IN HUMANS

Ruth Barral-Arca, Alberto Gómez-Carballa, Miriam Cebey-López, María José Currás-Tuala, Sara Pischedda, Sandra Viz-Lasheras, Xabier Bello, Federico Martinón-Torres and Antonio Salas

International J Molecular Sciences

Factor de impacto:

Q1

Doi:

Pubmed Full article

COST OF RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED ACUTE LOWER RESPIRATORY INFECTION MANAGEMENT IN YOUNG CHILDREN AT THE REGIONAL AND GLOBAL LEVEL: A SYSTEMATIC REVIEW AND META-ANALYSIS.

Zhang S, Akmar LZ, Bailey F, Rath BA, Alchikh M, Schweiger B, Lucero MG, Nillos LT, Kyaw MH, Kieffer A, Tong S, Campbell H, Beutels P, Nair H; RESCEU Investigators

J Infect Dis.

Factor de impacto:

Q1

Doi:

Pubmed Full article

IMMUNOLOGICAL AND INFLAMMATORY BIOMARKERS OF SUSCEPTIBILITY AND SEVERITY IN ADULT RESPIRATORY SYNCYTIAL VIRUS INFECTIONS.

Wiseman DJ, Thwaites RS, Drysdale SB, Janet S, Donaldson GC, Wedzicha JA, Openshaw PJ; RESCEU Investigators

J Infect Dis.

Factor de impacto:

Q1

Doi:

Pubmed Full article

LOW SENSITIVITY OF BINAXNOW RSV IN INFANTS.

Zuurbier RP, Bont LJ, Langedijk AC, Hamer M, Korsten K, Drysdale SB, Snape MD, Robinson H, Pollard AJ, Martinón-Torres F, Rodríguez-Tenreiro Sánchez C, Gómez-Carballa A, Dacosta-Urbieta AI, Heikkinen T, Cunningham S, van Houten MA, Wildenbeest JG; RESCEU Investigators .

J Infect Dis.

Factor de impacto:

Q1

Doi:

Pubmed Full article

PROTECTING THE MOST VULNERABLE AGE GROUP: A REVIEW OF MENACWY-TT IMMUNOGENICITY AND SAFETY IN INFANTS.

Martinón-Torres F, Serra L, Safadi MAP.

Expert Rev Vaccines

Factor de impacto:

Q2

Doi:

Pubmed Full article

PATHWAY TOWARDS AN IDEAL AND SUSTAINABLE FRAMEWORK AGREEMENT FOR THE PUBLIC PROCUREMENT OF VACCINES IN SPAIN: A MULTI-CRITERIA DECISION ANALYSIS.

Zozaya González N, Alcalá Revilla B, Arrazola Martínez P, Chávarri Bravo JR, Cuesta Esteve I, García Rojas A, Martinón-Torres F, Redondo Margüello E, Rivero Cuadrado A, Tamames Gómez S, Villaseca Carmena J, Hidalgo-Vega A

Hum Vaccine Immunother

Factor de impacto:

Q2

Doi:

Pubmed Full article

WHOLE-EXOME SEQUENCING FOR THE IDENTIFICATION OF RARE VARIANTS IN PRIMARY IMMUNODEFICIENCY GENES IN CHILDREN WITH SEPSIS - A PROSPECTIVE POPULATION-BASED COHORT STUDY

Alessandro Borghesi, Johannes Trück, Samira Asgari, Vanessa Sancho-Shimizu, Philipp KA Agyeman, Evangelos Bellos, Eric Giannoni, Martin Stocker, Klara M Posfay-Barbe, Ulrich Heininger, Sara Bernhard-Stirnemann, Anita Niederer-Loher, Christian R Kahlert, Giancardlo Natalucci, Christa Relly, Thomas Riedel, Claudia E Kuehni, Christian W. Thorball, Nimisha Chaturvedi, Federico Martinon-Torres, Taco W Kuijpers, Lachlan Coin, Victoria Wright, Jethro Herberg, Michael Levin, Christoph Aebi, Christoph Berger, Jacques Fellay, Luregn J Schlapbach, for the EUCLIDS consortium and the Swiss Paediatric Sepsis Study

Clin Infect Dis

Factor de impacto:

Q1

Doi:

Pubmed Full article

GENVIP is a research group dedicated to the study of infectious diseases and the development of vaccines using Omics tools.

The team is based in Santiago de Compostela, a historic World Heritage city with great cultural wealth and a long-established university tradition. The research group is part of the Health Research Institute of Santiago de Compostela [Instituto de Investigación Sanitaria de Santiago (IDIS)], an institution that brings together the strengths of the University of Santiago and the University Clinical Hospital of Santiago de Compostela.

Covid-19; parallel sequencing; NGS; exomes; whole-genome sequencing; gene expression; RNAseq; nanostring; proteomics; proteomics